Physician profile
Jeffrey Wilson
NPI 1962639237
$6,485.34
in general payments reported to CMS, 2019-2025
20 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,401 · 2020: $132 · 2021: $991 · 2022: $783 · 2023: $1,582 · 2024: $93.68 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398 · Travel and Lodging: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.35 |
| Travel and Lodging | $779.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,376.86 | 2019-2025 | Lithovue, Rezum Generator, Axonics |
| Axonics, INC. | $1,672.07 | 2022-2023 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $605.76 | 2019-2021 | |
| Palette Life Sciences, INC. | $179.40 | 2022 | |
| Myovant Sciences INC. | $125.00 | 2021 | |
| Endo Pharmaceuticals INC. | $100.84 | 2019-2023 | Xiaflex |
| Sumitomo Pharma America, INC. | $81.67 | 2024-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $75.51 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $49.48 | 2024-2025 | |
| Endo USA, INC. | $40.90 | 2025 | Xiaflex |
| Astellas Pharma US INC | $32.25 | 2019-2020 | |
| Teleflex LLC | $21.61 | 2025 | Urolift |
| Immunitybio, INC. | $19.07 | 2025 | |
| Calyxo, INC. | $16.67 | 2025 | Cvac Aspiration System |
| Medtronic, INC. | $15.84 | 2025 | Interstim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $15.64 | 2025 | |
| Baxter Healthcare | $15.44 | 2024 | Floseal |
| Procept Biorobotics Corporation | $14.64 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2019 | |
| Janssen Biotech, INC. | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.